☰

Tanea T. Reed, Ph.D. - Publications

Affiliations: 
University of Kentucky, Lexington, KY 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=41
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Butterfield DA, Boyd-Kimball D, Reed TT. CELLULAR STRESS RESPONSE (HORMESIS) IN RESPONSE TO BIOACTIVE NUTRACEUTICALS WITH RELEVANCE TO ALZHEIMER DISEASE. Antioxidants & Redox Signaling. PMID 36656673 DOI: 10.1089/ars.2022.0214  0.715
2016 Di Meo S, Reed TT, Venditti P, Victor VM. Harmful and Beneficial Role of ROS. Oxidative Medicine and Cellular Longevity. 2016: 7909186. PMID 27818723 DOI: 10.1155/2016/7909186  0.307
2016 Henderson M, Rice B, Sebastian A, Sullivan PG, King C, Robinson RA, Reed TT. Neuroproteomic study of nitrated proteins in moderate traumatic brain injured rats treated with gamma glutamyl cysteine ethyl ester administration post injury: Insight into the role of glutathione elevation in nitrosative stress. Proteomics. Clinical Applications. PMID 27739215 DOI: 10.1002/Prca.201600004  0.427
2016 Butterfield DA, Reed TT. Lipid Peroxidation and Tyrosine Nitration in Traumatic Brain Injury: Insights into Secondary Injury from Redox Proteomics. Proteomics. Clinical Applications. PMID 27588567 DOI: 10.1002/Prca.201600003  0.563
2016 Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxidative Medicine and Cellular Longevity. 2016: 1245049. PMID 27478531 DOI: 10.1155/2016/1245049  0.372
2015 Rice B, Reed T, Sowell R, King C. Restoration of enzymatic activity of energy related proteins in traumatic brain injured rats following the administration of gamma-glutamylcysteine ethyl ester The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.722.15  0.339
2012 Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxidants & Redox Signaling. 17: 1610-55. PMID 22115501 DOI: 10.1089/Ars.2011.4109  0.631
2012 Reed⁎ T, Motheral A. Treatment of moderate traumatic brain injury with GCEE: Insights into glutathione elevation Free Radical Biology and Medicine. 53: S247. DOI: 10.1016/J.Freeradbiomed.2012.08.037  0.324
2011 Reed TT. Lipid peroxidation and neurodegenerative disease. Free Radical Biology & Medicine. 51: 1302-19. PMID 21782935 DOI: 10.1016/J.Freeradbiomed.2011.06.027  0.443
2011 Butterfield DA, Reed T, Sultana R. Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radical Research. 45: 59-72. PMID 20942567 DOI: 10.3109/10715762.2010.520014  0.647
2011 Mohammed J, Henderson M, Williams R, Reed TT, Sultana R, Owen J. Quantitative Proteomic Analysis of Differentially Expressed Proteins in Aβ(17-42) Treated Synaptosomes Journal of the Kentucky Academy of Science. 72: 105-114. DOI: 10.3101/1098-7096-72.2.105  0.728
2009 Sultana R, Reed T, Butterfield DA. Detection of 4-hydroxy-2-nonenal- and 3-nitrotyrosine-modified proteins using a proteomics approach. Methods in Molecular Biology (Clifton, N.J.). 519: 351-61. PMID 19381594 DOI: 10.1007/978-1-59745-281-6_22  0.587
2009 Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Research. 1274: 66-76. PMID 19374891 DOI: 10.1016/J.Brainres.2009.04.009  0.682
2009 Reed TT, Owen J, Pierce WM, Sebastian A, Sullivan PG, Butterfield DA. Proteomic identification of nitrated brain proteins in traumatic brain-injured rats treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role of elevation of glutathione as a potential therapeutic strategy for traumatic brain injury. Journal of Neuroscience Research. 87: 408-17. PMID 18803298 DOI: 10.1002/Jnr.21872  0.662
2009 Reed TT, Pierce WM, Turner DM, Markesbery WR, Butterfield DA. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. Journal of Cellular and Molecular Medicine. 13: 2019-29. PMID 18752637 DOI: 10.1111/J.1582-4934.2008.00478.X  0.664
2008 Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiology of Disease. 30: 107-20. PMID 18325775 DOI: 10.1016/J.Nbd.2007.12.007  0.645
2008 Sultana R, Reed T, Butterfield DA. Redox Proteomics and Metabolic Proteins in Brain of Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Models Thereof Neural Degeneration and Repair: Gene Expression Profiling, Proteomics and Systems Biology. 181-207. DOI: 10.1002/9783527622467.ch9  0.549
2007 Sultana R, Reed T, Perluigi M, Coccia R, Pierce WM, Butterfield DA. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study. Journal of Cellular and Molecular Medicine. 11: 839-51. PMID 17760844 DOI: 10.1111/J.1582-4934.2007.00065.X  0.672
2007 Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology & Medicine. 43: 658-77. PMID 17664130 DOI: 10.1016/J.Freeradbiomed.2007.05.037  0.76
2007 Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Research. 1148: 243-8. PMID 17395167 DOI: 10.1016/J.Brainres.2007.02.084  0.662
2006 Butterfield DA, Abdul HM, Newman S, Reed T. Redox proteomics in some age-related neurodegenerative disorders or models thereof. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 344-57. PMID 16815218 DOI: 10.1016/J.Nurx.2006.05.003  0.725
2006 Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neuroscience Letters. 397: 170-3. PMID 16413966 DOI: 10.1016/J.Neulet.2005.12.017  0.631
2006 Poon HF, Shepherd HM, Reed TT, Calabrese V, Stella AM, Pennisi G, Cai J, Pierce WM, Klein JB, Butterfield DA. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiology of Aging. 27: 1020-34. PMID 15996793 DOI: 10.1016/J.Neurobiolaging.2005.05.014  0.58
2006 Butterfield DA, Abdul HM, Newman S, Reed T. Redox proteomics in some age-related neurodegenerative disorders or models thereof Neurotherapeutics. 3: 344-357. DOI: 10.1007/BF03206658  0.406
2004 Boyd-Kimball D, Abdul HM, Reed T, Sultana R, Butterfield DA. Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity Chemical Research in Toxicology. 17: 1743-1749. PMID 15606152 DOI: 10.1021/Tx049796W  0.727
Show low-probability matches.